SEARCH

SEARCH BY CITATION

References

  • ADAMS, I.B., TYAN, W., SINGER, M., THOMAS, B.F., COMPTON, D.R., RAZDAN, R.D. & MARTIN, B.R. (1995). Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther., 273, 11721181.
  • BERDYSHEV, E., BOICHOT, E., CORBEL, M., GERMAIN, N. & LAGENTE, V. (1998). Effect of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci., 63, PL125PL129.
  • BISOGNO, T., BERRENDERO, F., AMBROSINO, G., CEBEIRA, M., RAMOS, J.A., FERNANDEZ-RUIZ, J.J. & DI MARZO, V. (1999). Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun., 256, 377380.
  • BISOGNO, T., MAURELLI, S., MELCK, D., DE PETROCELLIS, L. & DI MARZO, V. (1997). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem., 272, 33153323.
  • CALIGNANO, A., LA RANA, G., MAKRIAYANNIS, A., LIN, S.Y., BELTRAMO, M. & PIOMELLI, D. (1997). Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur. J. Pharmacol., 340, R7R8.
  • CALIGNANO, A., LA RANA, G., GIUFFRIDA, A. & PIOMELLI, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394, 277281.
  • CAPASSO, R., FEZZA, F., IZZO, A.A., DI MARZO, V. & MASCOLO, N. (2001). Inhibitory effect of the cannabimimetic metabolite palmitoylethanolamide on intestinal motility in mice. Pharmacol. Res., 43, (Suppl A) 113.
  • DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686691.
  • DI MARZO, V. (1998). Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta, 1392, 153175.
  • EPPS, D.E., SCHMID, P.C., NATARAJAN, V. & SCHMID, H.H. (1979). N-acylethanolamine accumulation in infarcted myocardium. Biochem. Biophys. Res. Commun., 90, 628633.
  • FACCI, L., DAL TOSO, R., ROMANELLO, S., BURIANI, A., SKAPER, S.D. & LEON, A. (1995). Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A., 394, 277281.
  • FRIDE, E. (1995). Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol. Brain Res., 697, 8390.
  • GIUFFRIDA, A. & PIOMELLI, D. (1998). Isotope diluition GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett., 422, 373376.
  • GRIFFIN, G., TAO, Q. & ABOOD, M.E. (2000). Cloning and pharmacological characterization of the rat CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 292, 886894.
  • IZZO, A.A., CAPASSO, R., PINTO, L., DI CARLO, G., MASCOLO, N. & CAPASSO, F. (2001a). Effect of vanilloid drugs on gastrointestinal transit in mice. Br. J. Pharmacol., 132, 14111416.
  • IZZO, A.A., FEZZA, F., CAPASSO, R., BISOGNO, T., PINTO, L., IUVONE, T., ESPOSITO, G., MASCOLO, N., DI MARZO, V. & CAPASSO, F. (2001b). Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br. J. Pharmacol. in press.
  • IZZO, A.A., MASCOLO, N., BORRELLI, F. & CAPASSO, F. (1998). Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptor. Br. J. Pharmacol., 124, 13631368.
  • IZZO, A.A., MASCOLO, N. & CAPASSO, F. (2000). Marijuana in the new millennium: perspectives for cannabinoid research. Trends Pharmacol. Sci., 21, 281282.
  • KONDO, S., SUGIURA, T., KODAKA, T., KUDO, N., WAKU, K. & TOKUMURA, A. (1998). Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. Arch. Biochem. Biophys., 354, 303310.
  • KUEHL, F.A., JACOB, T.A., GANLEY, O.H., ORMOND, R.E. & MEISINGER, M.A.P. (1957). The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J. Am. Chem. Soc., 79, 55775578.
  • LAMBERT, D.M. & DI MARZO, V. (1999). The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic Curr. Med. Chem., 6, 757773.
  • PERTWEE, R.G., FERNANDO, S.R., GRIFFIN, G., ABADJI, V. & MAKRIAYANNIS, A. (1995). Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol., 272, 7378.
  • PUIG, M.M. & POL, O. (1998). Peripheral effects of opioids in a model of chronic intestinal inflammation in mice. J. Pharmacol. Exp. Ther., 284, 644650.
  • ROSS, R.A., BROCKIE, H.C. & PERTWEE, R.G. (2000). Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide. Eur. J. Pharmacol., 401, 121130.
  • SANTOS, R.A. & RAO, V.S.M. (1999). Quinine-induced inhibition of gastrointestinal transit in mice: possible involvement of endogenous opioids. Eur. J. Pharmacol., 364, 193197.
  • SCHMID, P.C., KUWAE, T., KREBSBACH, R.J. & SCHMID, H.H. (1997). Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. Chem. Phys. Lipids., 87, 103110.
  • TALLARIDA, R.J. & MURRAY, R.B. (1986). Manual of pharmacological calculations with computer programs. New York: Springer-Verlag.
  • UEDA, N., YAMANAKA, K., TERASAWA, Y. & YAMAMOTO, S. (1999). An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett., 454, 267270.
  • WHITE, R. & HILEY, R. (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533541.
  • WILEY, J.L., DEWEY, M.A., JEFFERSON, R.G., WINCLER, R.L., TROY BRIDGEN, D., WILLOUGHBY, K.A. & MARTIN, B.R. (2000). Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci., 67, 15731583.